Voices: Challenges and opportunities for bioorthogonal chemistry.
| Autor: | Hsu KL, Schumann B, Sletten E, Vinogradova E, Zou P |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cell chemical biology [Cell Chem Biol] 2024 Mar 21; Vol. 31 (3), pp. 380-382. |
| DOI: | 10.1016/j.chembiol.2024.02.010 |
| Abstrakt: | Bioorthogonal chemistry was deservedly recognized with the 2022 Nobel Prize in Chemistry, having transformed the way chemists and biologists interrogate biological systems in the past twenty years. This Voices piece asks researchers from a range of backgrounds: what are some major challenges and opportunities facing the field in coming years? Competing Interests: Declaration of interests Ku-Lung Hsu is a founder and scientific advisory board member of Hyku Biosciences. Ellen Sletten is a co-author on three patents related to bioorthogonal chemistry. (Copyright © 2024. Published by Elsevier Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|